• Profile
Close

A systematic review and a dose-response meta-analysis of coffee dose and nonalcoholic fatty liver disease

Clinical Nutrition Dec 11, 2018

Chen YP, et al. - Researchers conducted this systematic review and a dose-response meta-analysis to investigate the impact of coffee on nonalcoholic fatty liver disease (NAFLD) risk and its potential dose-response trends. Up until April 10, 2018, they searched the PubMed, Web of Science, MEDLINE, Cochrane, and Embase databases for relevant studies. A total of 7 eligible articles with 4,825 cases and 49,616 non-cases were identified. According to the findings obtained, consumption of > 3 cups of coffee were observed at a lower risk of NAFLD than < 2 cups per day. While the risk of NAFLD was inversely related to coffee consumption, the relevance may not be very close.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay